Chronic stress is associated with hormonal changes that are known to affect multiple systems, including the immune and endocrine systems, but the effects of stress on cancer growth and progression are not fully understood. Here, we demonstrate that human ovarian cancer cells exposed to either norepinephrine or epinephrine exhibit lower levels of anoikis, the process by which cells enter apoptosis when separated from ECM and neighboring cells. In an orthotopic mouse model of human ovarian cancer, restraint stress and the associated increases in norepinephrine and epinephrine protected the tumor cells from anoikis and promoted their growth by activating focal adhesion kinase (FAK). These effects involved phosphorylation of FAKY397, which was itself associated with actin-dependent Src interaction with membrane-associated FAK. Importantly, in human ovarian cancer patients, behavioral states related to greater adrenergic activity were associated with higher levels of pFAKY397, which was in turn linked to substantially accelerated mortality. These data suggest that FAK modulation by stress hormones, especially norepinephrine and epinephrine, can contribute to tumor progression in patients with ovarian cancer and may point to potential new therapeutic targets for cancer management.
Anil K. Sood, Guillermo N. Armaiz-Pena, Jyotsnabaran Halder, Alpa M. Nick, Rebecca L. Stone, Wei Hu, Amy R. Carroll, Whitney A. Spannuth, Michael T. Deavers, Julie K. Allen, Liz Y. Han, Aparna A. Kamat, Mian M.K. Shahzad, Bradley W. McIntyre, Claudia M. Diaz-Montero, Nicholas B. Jennings, Yvonne G. Lin, William M. Merritt, Koen DeGeest, Pablo E. Vivas-Mejia, Gabriel Lopez-Berestein, Michael D. Schaller, Steven W. Cole, Susan K. Lutgendorf
Title and authors | Publication | Year |
---|---|---|
Silencing ZIC2 abrogates tumorigenesis and anoikis resistance of non-small cell lung cancer cells by inhibiting Src/FAK signaling
A Liu, H Xie, R Li, L Ren, B Yang, L Dai, W Lu, B Liu, D Ren, X Zhang, Q Chen, Y Huang, K Shi |
Molecular Therapy — Oncolytics | 2021 |
New-Onset Cancer in the HF Population: Epidemiology, Pathophysiology, and Clinical Management
A Cuomo, F Paudice, G DAngelo, G Perrotta, A Carannante, U Attanasio, M Iengo, F Fiore, CG Tocchetti, V Mercurio, F Pirozzi |
Current Heart Failure Reports | 2021 |
Tumor Microenvironment: Novel Concepts
A Birbrair |
2021 | |
Blood Vessels and Peripheral Nerves as Key Players in Cancer Progression and Therapy Resistance
N Roda, G Blandano, PG Pelicci |
Cancers | 2021 |
Stress Hormones: Emerging Targets in Gynecological Cancers
G Chen, L Qiu, J Gao, J Wang, J Dang, L Li, Z Jin, X Liu |
Frontiers in Cell and Developmental Biology | 2021 |
Stress and cancer: mechanisms, significance and future directions
A Eckerling, I Ricon-Becker, L Sorski, E Sandbank, S Ben-Eliyahu |
Nature Reviews Cancer | 2021 |
Cancer and Stress: Does It Make a Difference to the Patient When These Two Challenges Collide?
A Iftikhar, M Islam, S Shepherd, S Jones, I Ellis |
Cancers | 2021 |
Assessment of Epinephrine and Norepinephrine in Gastric Carcinoma
AM Mehedințeanu, V Sfredel, PO Stovicek, M Schenker, GC Târtea, O Istrătoaie, AM Ciurea, CC Vere |
International journal of molecular sciences | 2021 |
Phase II study of propranolol feasibility with neoadjuvant chemotherapy in patients with newly diagnosed breast cancer
MB Hopson, S Lee, M Accordino, M Trivedi, M Maurer, KD Crew, DL Hershman, K Kalinsky |
Breast Cancer Research and Treatment | 2021 |
Predicting therapeutic drugs for hepatocellular carcinoma based on tissue-specific pathways
L Yu, M Wang, Y Yang, F Xu, X Zhang, F Xie, L Gao, X Li, J Gallo |
PLoS computational biology | 2021 |
Effects of long-term norepinephrine treatment on normal immortalized ovarian and fallopian tube cells
S Dash, S Yoder, T Mesa, A Smith, L Cen, S Eschrich, GN Armaiz-Pena, AN Monteiro |
Scientific Reports | 2021 |
Chronic Stress Activates PlexinA1/VEGFR2-JAK2-STAT3 in Vascular Endothelial Cells to Promote Angiogenesis
YJ Lu, HZ Zhao, Y Liu, YZ Zuo, Q Xu, L Liu, XM Li, HB Zhu, Y Zhang, S Zhang, XY Zhao, YH Li |
Frontiers in Oncology | 2021 |
Subclinical cardiac damage in cancer patients before chemotherapy
I Fabiani, G Panichella, A Aimo, C Grigoratos, G Vergaro, NR Pugliese, S Taddei, DM Cardinale, C Passino, M Emdin, A Giannoni |
Heart Failure Reviews | 2021 |
Immunomodulatory Effects of Perioperative Dexmedetomidine in Ovarian Cancer: An In Vitro and Xenograft Mouse Model Study
S Shin, KJ Kim, HJ Hwang, S Noh, JE Oh, YC Yoo |
Frontiers in Oncology | 2021 |
Norepinephrine Enhances Aerobic Glycolysis and May Act as a Predictive Factor for Immunotherapy in Gastric Cancer
Y Wang, S Wang, Q Yang, J Li, F Yu, E Zhao, J Ji |
Journal of Immunology Research | 2021 |
LIM domain-containing 2 (LIMD2) promotes the progress of ovarian cancer via the focal adhesion signaling pathway
L Chen, J Qian, Q You, J Ma |
Bioengineered | 2021 |